Cargando…

Carisoprodol Abuse in Adolescence

Carisoprodol (i.e. Soma, Soprodol, Vanadom) is a muscle relaxant prescribed to relieve symptoms of muscle pain. Carisoprodol's addiction potential in adults has been well-established through case reports in the past. Carisoprodol abuse in adolescents has been reported in the ‘Monitoring the Fut...

Descripción completa

Detalles Bibliográficos
Autor principal: Gupta, Mayank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746313/
https://www.ncbi.nlm.nih.gov/pubmed/33354469
http://dx.doi.org/10.7759/cureus.11525
_version_ 1783624771355803648
author Gupta, Mayank
author_facet Gupta, Mayank
author_sort Gupta, Mayank
collection PubMed
description Carisoprodol (i.e. Soma, Soprodol, Vanadom) is a muscle relaxant prescribed to relieve symptoms of muscle pain. Carisoprodol's addiction potential in adults has been well-established through case reports in the past. Carisoprodol abuse in adolescents has been reported in the ‘Monitoring the Future’ study since 2007, but no case studies or research has been published to date. Due to its relatively short half-life, tolerance and dependence develop quite quickly, leading to negative mental health outcomes. Awareness and education among health care providers remain critical to screen and treat this condition.
format Online
Article
Text
id pubmed-7746313
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-77463132020-12-21 Carisoprodol Abuse in Adolescence Gupta, Mayank Cureus Psychiatry Carisoprodol (i.e. Soma, Soprodol, Vanadom) is a muscle relaxant prescribed to relieve symptoms of muscle pain. Carisoprodol's addiction potential in adults has been well-established through case reports in the past. Carisoprodol abuse in adolescents has been reported in the ‘Monitoring the Future’ study since 2007, but no case studies or research has been published to date. Due to its relatively short half-life, tolerance and dependence develop quite quickly, leading to negative mental health outcomes. Awareness and education among health care providers remain critical to screen and treat this condition. Cureus 2020-11-17 /pmc/articles/PMC7746313/ /pubmed/33354469 http://dx.doi.org/10.7759/cureus.11525 Text en Copyright © 2020, Gupta et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Psychiatry
Gupta, Mayank
Carisoprodol Abuse in Adolescence
title Carisoprodol Abuse in Adolescence
title_full Carisoprodol Abuse in Adolescence
title_fullStr Carisoprodol Abuse in Adolescence
title_full_unstemmed Carisoprodol Abuse in Adolescence
title_short Carisoprodol Abuse in Adolescence
title_sort carisoprodol abuse in adolescence
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746313/
https://www.ncbi.nlm.nih.gov/pubmed/33354469
http://dx.doi.org/10.7759/cureus.11525
work_keys_str_mv AT guptamayank carisoprodolabuseinadolescence